NovoCure Aktie

NovoCure für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A140ML / ISIN: JE00BYSS4X48

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
30.10.2025 13:53:13

Novocure Posts Wider Loss In Q3

(RTTNews) - Novocure (NVCR) reported a third quarter net loss of $37.3 million compared to a loss of $30.6 million, prior year. Net loss per ordinary share was $0.33 compared to a loss of $0.28. Analysts on average expected the company to report a loss per share of $0.42, for the quarter. Analysts' estimates typically exclude special items.

Total net revenues for the quarter were $167.2 million, an increase of 8% compared to the same period in 2024. The company said this increase was primarily driven by active patient growth, as well as $3.3 million in exchange rate benefits.

Shares of Novocure are up 7% in pre-market trade on Thursday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Analysen zu NovoCure Limitedmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

NovoCure Limited 11,08 -3,99% NovoCure Limited